The appetite-suppressing effect of semaglutide GLP-1 if is gradual
Some discount chains may bill you directly, though
Department of Health and Human Services, Food and Drug Administration, Human Drug Compounding, updated 12/18/2024
Research suggests that GLP-1 receptor agonists may reduce the hedonic or pleasure-driven aspects of eating, potentially making high-calorie, palatable foods less appealing
Additionally, symptoms that could indicate pancreatitis (severe abdominal pain radiating to the back, persistent vomiting) or gallbladder disease (right upper quadrant pain, fever, jaundice) require urgent evaluation, as these are known potential complications of GLP-1 therapy